CAMP4 Therapeutics Corporation (CAMP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 186.23M |
| Enterprise Value | 78.69M |
| P/E Ratio | -1.9 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 23.27 |
| Price/Book Ratio | 8.08 |
| Enterprise/Revenue | -1.41 |
| Enterprise/EBITDA | 0.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -21.94 |
| Operating Margin | -13.23 |
AD
Management Effectiveness
| Return On Assets | -0.82 |
| Return On Equity | -1.95 |
Income Statement
| Revenue | 3.5M |
| Revenue/Share | 0.07 |
| Gross Profit | 1.86M |
| EBITDA | -50.42M |
| Net Income | -80.4M |
| Diluted EPS | -2.65 |
Balance Sheet
| Total Cash | 99.21M |
| Total Cash/Share | 1.71 |
| Total Debt | 2.12M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 6.15 |
| Book Value Per Share | 0.53 |
Price History
| 52-Week Change | 193.2 |
| 52-Week High | 7.75 |
| 52-Week Low | 1.32 |
| Moving Average 50 Days | 4.24 |
| Moving Average 200 Days | 4.38 |
Statistics
| Average Volume | 171,573 |
| Shares Outstanding | 21.24M |
| % Held by Institutions | 76.65 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | March 25, 1996 |
AD
